Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia NCT02877303 B Acute Lymphob...
B Lymphoblastic...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Laboratory Biom...
Mercaptopurine
Methotrexate
Ofatumumab
Prednisone
Rituximab
Vincristine Sul...
14 Years - M.D. Anderson Cancer Center View NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma NCT01451515 Lymphoblastic L...
Prednisone
Vincristine
Daunorubicin
PEG-asparaginas...
Erwinia asparag...
Doxorubicin
Cyclophosphamid...
Cytarabine
Thioguanine
Clofarabine
Methotrexate
Mercaptopurine
Dexamethasone
Hydrocortisone
Etoposide
- 21 Years St. Jude Children's Research Hospital View Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission NCT00268528 Childhood Acute...
Compliance Moni...
Laboratory Biom...
Mercaptopurine
Methotrexate
Questionnaire A...
Study of Socioe...
- 21 Years Children's Oncology Group View Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) NCT06210750 T Acute Lymphob...
T Lymphoblastic...
Biospecimen Col...
Bone Marrow Asp...
Bone Marrow Bio...
Calaspargase Pe...
Computed Tomogr...
Cyclophosphamid...
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Echocardiograph...
Lumbar Puncture
Mercaptopurine
Methotrexate
Multigated Acqu...
Navitoclax
Nelarabine
Pegaspargase
Positron Emissi...
Thioguanine
Venetoclax
Vincristine
X-Ray Imaging
18 Years - 60 Years National Cancer Institute (NCI) View Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia NCT00002785 Leukemia
filgrastim
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
mesna
methotrexate
methylprednisol...
pegaspargase
prednisone
therapeutic hyd...
vincristine sul...
allogeneic bone...
low-LET cobalt-...
low-LET photon ...
- 1 Year Children's Oncology Group View Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia NCT00613457 Leukemia
dexamethasone
asparaginase
Asparaginase
cyclophosphamid...
cytarabine
daunorubicin
doxorubicin
Etoposide
Ifosfamide
mercaptopurine
Methotrexate
prednisone
thioguanine
Vincristine
Vindesine
1 Year - 17 Years Associazione Italiana Ematologia Oncologia Pediatrica View Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma NCT00408005 T Acute Lymphob...
T Lymphoblastic...
Asparaginase
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years National Cancer Institute (NCI) View Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma NCT00275106 Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisolone
thioguanine
vincristine sul...
radiation thera...
- 21 Years National Cancer Institute (NCI) View Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia NCT00381680 B-cell Childhoo...
L1 Childhood Ac...
L2 Childhood Ac...
Intermediate Ri...
vincristine sul...
prednisone
doxorubicin hyd...
pegaspargase
cytarabine
methotrexate
dexamethasone
etoposide
cyclophosphamid...
leucovorin calc...
filgrastim
asparaginase
mercaptopurine
1 Year - 29 Years Children's Oncology Group View Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00002756 Leukemia
filgrastim
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
leucovorin calc...
mercaptopurine
methotrexate
prednisone
therapeutic hyd...
vincristine sul...
- 1 Year Children's Oncology Group View Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia NCT02101853 Recurrent B Acu...
Allogeneic Hema...
Asparaginase
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Etoposide
Leucovorin Calc...
Mercaptopurine
Methotrexate
Mitoxantrone
Mitoxantrone Hy...
Pegaspargase
Pharmacological...
Radiation Thera...
Therapeutic Hyd...
Thioguanine
Vincristine
Vincristine Sul...
1 Year - 31 Years National Cancer Institute (NCI) View Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia NCT03488225 Acute Lymphobla...
B Acute Lymphob...
B Acute Lymphob...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Ofatumumab
Prednisone
Rituximab
Vincristine Sul...
16 Years - M.D. Anderson Cancer Center View Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00002744 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 Years Children's Oncology Group View Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment NCT02881086 Acute Lymphobla...
Lymphoblastic L...
Rituximab
Nelarabine
PEG-Asparaginas...
Cranial irradia...
Imatinib
Idarubicin
Dexamethasone
Cyclophosphamid...
Fludarabine
Vincristine
Mercaptopurine
VP16
Daunorubicin (D...
Methotrexate
Stem cell trans...
Cytarabine
Vindesine
Adriamycin
Prednisolone
18 Years - 55 Years Goethe University View S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00109837 Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin
dexamethasone
doxorubicin
leucovorin
mercaptopurine
methotrexate
mitoxantrone
Asparaginase
prednisone
thioguanine
vincristine
radiation thera...
allopurinol
bactrim
18 Years - 64 Years SWOG Cancer Research Network View Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma NCT05032183 Recurrent Adult...
Recurrent B Acu...
Recurrent T Acu...
Refractory B Ac...
Refractory Lymp...
Refractory T Ac...
Cyclophosphamid...
Cytarabine
Dexamethasone
Filgrastim-sndz
Leucovorin
Mercaptopurine
Mesna
Methotrexate
Pegfilgrastim
Prednisone
Rituximab
Tagraxofusp-erz...
Vincristine
18 Years - 70 Years M.D. Anderson Cancer Center View Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia NCT04770922 Acute Lymphobla...
Adverse Drug Ev...
- 21 Years Cipherome, Inc. View Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia NCT03488225 Acute Lymphobla...
B Acute Lymphob...
B Acute Lymphob...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Ofatumumab
Prednisone
Rituximab
Vincristine Sul...
16 Years - M.D. Anderson Cancer Center View Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia NCT00550992 Leukemia
anti-thymocyte ...
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
leucovorin calc...
melphalan
mercaptopurine
methotrexate
mitoxantrone hy...
pegaspargase
prednisolone
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
allogeneic bone...
allogeneic hema...
umbilical cord ...
- 1 Year Dutch Childhood Oncology Group View Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT01256398 Acute Lymphobla...
Adult B Acute L...
Alemtuzumab
Allogeneic Hema...
Autologous Hema...
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Etoposide Phosp...
Filgrastim
Fludarabine Pho...
In Vitro-Treate...
Laboratory Biom...
Leucovorin Calc...
Melphalan
Mercaptopurine
Methotrexate
Pegfilgrastim
Pharmacological...
Tacrolimus
Vincristine Sul...
18 Years - National Cancer Institute (NCI) View Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia NCT02776605 ALL
Prednisone
Vincristine
Daunorubicin
Prednisone
Ponatinib
Mercaptopurine
Methotrexate
VP-16
ARA-C:
TIT
Ponatinib
Autologous tran...
Allo transplant...
18 Years - 55 Years PETHEMA Foundation View Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma NCT01700946 Recurrent B-Cel...
Recurrent Child...
dexamethasone
vincristine sul...
rituximab
clofarabine
cyclophosphamid...
etoposide
aldesleukin
pegaspargase
methotrexate
mercaptopurine
cytarabine
mitoxantrone
teniposide
vinblastine
natural killer ...
laboratory biom...
therapeutic hyd...
allogeneic hema...
CliniMACS
- 21 Years St. Jude Children's Research Hospital View Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia NCT00002704 Leukemia
filgrastim
asparaginase
cyclophosphamid...
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
liposomal cytar...
mercaptopurine
mesna
methotrexate
therapeutic hyd...
thiotepa
vincristine sul...
low-LET electro...
low-LET photon ...
- 20 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations NCT02883049 B Acute Lymphob...
B Acute Lymphob...
Central Nervous...
Testicular Leuk...
Clofarabine
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Etoposide
Hydrocortisone ...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 31 Years National Cancer Institute (NCI) View Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil NCT05959720 Acute Lymphoid ...
Minimal Residua...
Gene Abnormalit...
Chemotherapeuti...
Prednisone
Vincristin
Daunorubicin
Peg-asparaginas...
Intrathecal Sus...
Cyclophosphamid...
Cytarabine
Mercaptopurine
Methotrexate
Doxorubicin
16 Years - 50 Years Instituto do Cancer do Estado de São Paulo View Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia NCT00002704 Leukemia
filgrastim
asparaginase
cyclophosphamid...
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
liposomal cytar...
mercaptopurine
mesna
methotrexate
therapeutic hyd...
thiotepa
vincristine sul...
low-LET electro...
low-LET photon ...
- 20 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma NCT00408005 T Acute Lymphob...
T Lymphoblastic...
Asparaginase
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years National Cancer Institute (NCI) View Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma NCT01190930 Acute Lymphobla...
Adult B Lymphob...
Ann Arbor Stage...
Ann Arbor Stage...
Childhood B Acu...
Childhood B Acu...
Childhood B Lym...
Down Syndrome
Hypodiploid B A...
Philadelphia Ch...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Quality-of-Life...
Questionnaire A...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00002744 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 Years Children's Oncology Group View Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia NCT00005603 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sul...
1 Year - 21 Years Children's Oncology Group View LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive NCT00526305 Acute Lymphobla...
Vincristine
Daunorubicin
Prednisone
L-Asparaginase
Mitoxantrone
Cytosine Arabin...
Hydrocortisone
Mercaptopurine
Cyclophosphamid...
Dexamethasone
- 65 Years PETHEMA Foundation View Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia NCT02776605 ALL
Prednisone
Vincristine
Daunorubicin
Prednisone
Ponatinib
Mercaptopurine
Methotrexate
VP-16
ARA-C:
TIT
Ponatinib
Autologous tran...
Allo transplant...
18 Years - 55 Years PETHEMA Foundation View Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm NCT04216524 Blastic Plasmac...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin
Mercaptopurine
Methotrexate
Methylprednisol...
Prednisone
Rituximab
Tagraxofusp-erz...
Venetoclax
Vincristine
18 Years - M.D. Anderson Cancer Center View Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma NCT01230983 Cardiac Toxicit...
Leukemia
Lymphoma
asparaginase
cytarabine
dexrazoxane hyd...
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
therapeutic hyd...
vincristine sul...
radiation thera...
- 21 Years Children's Oncology Group View Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations NCT02883049 B Acute Lymphob...
B Acute Lymphob...
Central Nervous...
Testicular Leuk...
Clofarabine
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Etoposide
Hydrocortisone ...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 31 Years National Cancer Institute (NCI) View Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment NCT02881086 Acute Lymphobla...
Lymphoblastic L...
Rituximab
Nelarabine
PEG-Asparaginas...
Cranial irradia...
Imatinib
Idarubicin
Dexamethasone
Cyclophosphamid...
Fludarabine
Vincristine
Mercaptopurine
VP16
Daunorubicin (D...
Methotrexate
Stem cell trans...
Cytarabine
Vindesine
Adriamycin
Prednisolone
18 Years - 55 Years Goethe University View Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage NCT04440267 Acute Leukemia ...
vincristine
daunorubicin
cyclophosphamid...
L-Asparaginase
prednisone
mercaptopurine
methotrexate
dexamethasone
Tyrosine kinase...
14 Years - Institute of Hematology & Blood Diseases Hospital, China View Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia NCT00002531 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
etoposide
ifosfamide
leucovorin calc...
mercaptopurine
methotrexate
mitoxantrone hy...
prednisolone
teniposide
thioguanine
vincristine sul...
vindesine
allogeneic bone...
peripheral bloo...
radiation thera...
15 Years - 65 Years National Cancer Institute (NCI) View Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia NCT02036489 Acute Lymphobka...
Vincristine
Daunorubicin
Prednisone
L-asparaginase
Ciclophosphamid...
Metotrexate
ARA-C
Hidrocortisone
Mercaptopurine
VP-16
Dexametasone
15 Years - PETHEMA Foundation View Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia NCT02003222 Acute Lymphobla...
B Acute Lymphob...
Allogeneic Hema...
Biospecimen Col...
Blinatumomab
Bone Marrow Asp...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Etoposide
Lumbar Puncture
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Rituximab
Vincristine
Vincristine Sul...
X-Ray Imaging
30 Years - 70 Years National Cancer Institute (NCI) View Treatment of High Risk Adult Acute Lymphoblastic Leukemia NCT00853008 Acute Lymphobla...
Vincristine
Daunorubicin
Prednisone
Mitoxantrone
Cytosine Arabin...
Dexamethasone
Methotrexate (M...
Cytarabine
ASP
Mercaptopurine
Teniposide
Hydrocortisone
16 Years - PETHEMA Foundation View Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma NCT03117751 Acute Lymphobla...
Acute Lymphobla...
Prednisone
Vincristine
Daunorubicin
Pegaspargase
Erwinase®
Cyclophosphamid...
Cytarabine
Mercaptopurine
Dasatinib
Methotrexate
Blinatumomab
Ruxolitinib
Bortezomib
Dexamethasone
Doxorubicin
Etoposide
Clofarabine
Vorinostat
Idarubicin
Nelarabine
Thioguanine
Asparaginase Er...
Calaspargase Pe...
1 Year - 18 Years St. Jude Children's Research Hospital View Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00557193 Acute Lymphobla...
Acute Undiffere...
Childhood T Acu...
Asparaginase
Biospecimen Col...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Echocardiograph...
Etoposide
Filgrastim
Laboratory Biom...
Lestaurtinib
Leucovorin Calc...
Mercaptopurine
Methotrexate
Methylprednisol...
Multigated Acqu...
Pegaspargase
Pharmacological...
Prednisone
Therapeutic Hyd...
Vincristine Sul...
- 1 Year Children's Oncology Group View Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) NCT00131053 Lymphoblastic L...
Methotrexate
Prednisolone
Dexamethasone
Vincristine
Pirarubicin
Cyclophosphamid...
L-asparaginase
Cytarabine
Hydrocortisone
Mercaptopurine
15 Years - 24 Years Japan Adult Leukemia Study Group View Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes NCT00096135 Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
methotrexate
pegaspargase
therapeutic hyd...
vincristine sul...
radiation thera...
18 Months - 29 Years Children's Oncology Group View Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma NCT02141100 Non-Hodgkin Lym...
6-thioguanine
2 Years - 18 Years Rigshospitalet, Denmark View Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma NCT00004228 Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 30 Years Children's Oncology Group View A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia NCT03914625 B Acute Lymphob...
B Lymphoblastic...
Down Syndrome
Asparaginase Er...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Mercaptopurine ...
Methotrexate
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Radiation Thera...
Thioguanine
Vincristine Sul...
365 Days - 31 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia NCT00002812 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
idarubicin
mercaptopurine
methotrexate
pegaspargase
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 21 Years Children's Oncology Group View Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia NCT00613457 Leukemia
dexamethasone
asparaginase
Asparaginase
cyclophosphamid...
cytarabine
daunorubicin
doxorubicin
Etoposide
Ifosfamide
mercaptopurine
Methotrexate
prednisone
thioguanine
Vincristine
Vindesine
1 Year - 17 Years Associazione Italiana Ematologia Oncologia Pediatrica View Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia NCT00061945 Acute Undiffere...
B-cell Adult Ac...
B-cell Childhoo...
L1 Adult Acute ...
L1 Childhood Ac...
L2 Adult Acute ...
L2 Childhood Ac...
Philadelphia Ch...
Philadelphia Ch...
Philadelphia Ch...
T-cell Adult Ac...
T-cell Childhoo...
Untreated Adult...
Untreated Child...
allopurinol
cyclophosphamid...
daunorubicin hy...
vincristine sul...
dexamethasone
asparaginase
filgrastim
imatinib mesyla...
methotrexate
cytarabine
trimethoprim-su...
mercaptopurine
leucovorin calc...
alemtuzumab
acyclovir
laboratory biom...
pharmacological...
15 Years - National Cancer Institute (NCI) View Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia NCT00022126 Leukemia
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
methylprednisol...
pegaspargase
thioguanine
vincristine sul...
allogeneic bone...
radiation thera...
- 1 Year Children's Oncology Group View Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia NCT00003671 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
leucovorin calc...
mercaptopurine
methotrexate
thioguanine
vincristine sul...
- 18 Years Children's Oncology Group View Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia NCT00089349 Recurrent Child...
alemtuzumab
methotrexate
mercaptopurine
- 30 Years National Cancer Institute (NCI) View Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia NCT02877303 B Acute Lymphob...
B Lymphoblastic...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Laboratory Biom...
Mercaptopurine
Methotrexate
Ofatumumab
Prednisone
Rituximab
Vincristine Sul...
14 Years - M.D. Anderson Cancer Center View A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL) NCT06124157 B Acute Lymphob...
Biospecimen Col...
Blinatumomab
Bone Marrow Bio...
Calaspargase Pe...
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin
Doxorubicin
Echocardiograph...
Leucovorin
Mercaptopurine
Methotrexate
Multigated Acqu...
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Thioguanine
Vincristine
366 Days - 46 Years National Cancer Institute (NCI) View Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement NCT02828358 Acute Leukemia ...
B Acute Lymphob...
Mixed Phenotype...
Azacitidine
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Hydrocortisone ...
Laboratory Biom...
Leucovorin
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Pharmacological...
Prednisolone
Thioguanine
Vincristine
Vincristine Sul...
- 364 Days National Cancer Institute (NCI) View Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma NCT05303792 B Acute Lymphob...
B Lymphoblastic...
Cyclophosphamid...
Vincristine
Dexamethasone
Inotuzumab Ozog...
Methotrexate
Cytarabine
Methylprednisol...
Rituximab
Prednisone
Mercaptopurine
Doxorubicin
50 Years - Alliance for Clinical Trials in Oncology View Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia NCT00276601 Leukemia
arsenic trioxid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
tretinoin
5 Years - 74 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia NCT00276601 Leukemia
arsenic trioxid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
tretinoin
5 Years - 74 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia NCT02003222 Acute Lymphobla...
B Acute Lymphob...
Allogeneic Hema...
Biospecimen Col...
Blinatumomab
Bone Marrow Asp...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Etoposide
Lumbar Puncture
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Rituximab
Vincristine
Vincristine Sul...
X-Ray Imaging
30 Years - 70 Years National Cancer Institute (NCI) View Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes NCT00096135 Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
methotrexate
pegaspargase
therapeutic hyd...
vincristine sul...
radiation thera...
18 Months - 29 Years Children's Oncology Group View Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia NCT00003934 Adult Acute Mye...
Adult Acute Pro...
Childhood Acute...
Untreated Adult...
Untreated Child...
tretinoin
daunorubicin hy...
cytarabine
mercaptopurine
methotrexate
arsenic trioxid...
- National Cancer Institute (NCI) View Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia NCT00381680 B-cell Childhoo...
L1 Childhood Ac...
L2 Childhood Ac...
Intermediate Ri...
vincristine sul...
prednisone
doxorubicin hyd...
pegaspargase
cytarabine
methotrexate
dexamethasone
etoposide
cyclophosphamid...
leucovorin calc...
filgrastim
asparaginase
mercaptopurine
1 Year - 29 Years Children's Oncology Group View A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia NCT03914625 B Acute Lymphob...
B Lymphoblastic...
Down Syndrome
Asparaginase Er...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Mercaptopurine ...
Methotrexate
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Radiation Thera...
Thioguanine
Vincristine Sul...
365 Days - 31 Years National Cancer Institute (NCI) View Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission NCT01503632 Acute Lymphobla...
Behavioral Inte...
Compliance Moni...
Laboratory Biom...
Mercaptopurine
Questionnaire A...
Standard Follow...
1 Year - 21 Years Children's Oncology Group View Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma NCT00018954 Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
doxorubicin hyd...
etoposide
ifosfamide
mercaptopurine
methotrexate
prednisone
vincristine sul...
conventional su...
radiation thera...
- National Institutes of Health Clinical Center (CC) View Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia NCT00002700 Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
mitoxantrone hy...
prednisolone
prednisone
therapeutic hyd...
vincristine sul...
allogeneic bone...
autologous bone...
radiation thera...
15 Years - 60 Years European Organisation for Research and Treatment of Cancer - EORTC View Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil NCT05959720 Acute Lymphoid ...
Minimal Residua...
Gene Abnormalit...
Chemotherapeuti...
Prednisone
Vincristin
Daunorubicin
Peg-asparaginas...
Intrathecal Sus...
Cyclophosphamid...
Cytarabine
Mercaptopurine
Methotrexate
Doxorubicin
16 Years - 50 Years Instituto do Cancer do Estado de São Paulo View Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma NCT05303792 B Acute Lymphob...
B Lymphoblastic...
Cyclophosphamid...
Vincristine
Dexamethasone
Inotuzumab Ozog...
Methotrexate
Cytarabine
Methylprednisol...
Rituximab
Prednisone
Mercaptopurine
Doxorubicin
50 Years - Alliance for Clinical Trials in Oncology View Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents NCT03020030 Acute Lymphobla...
Pegaspargase
Erwinia asparag...
Cyclophosphamid...
CYTARABINE
DASATINIB
DEXAMETHASONE
Dexrazoxane
Doxorubicin
ETOPOSIDE
HYDROCORTISONE
LEUCOVORIN CALC...
MERCAPTOPURINE
METHOTREXATE
NELARABINE
Vincristine
1 Year - 21 Years Dana-Farber Cancer Institute View Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia NCT00075725 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia NCT03150693 B Acute Lymphob...
Allopurinol
Cytarabine
Daunorubicin Hy...
Vincristine Sul...
Dexamethasone
Pegylated L-Asp...
Methotrexate
Bone Marrow Asp...
Cyclophosphamid...
Mercaptopurine
Rituximab
Doxorubicin
Thioguanine
Inotuzumab Ozog...
Laboratory Biom...
18 Years - 39 Years Alliance for Clinical Trials in Oncology View Treatment of High Risk Adult Acute Lymphoblastic Leukemia NCT00853008 Acute Lymphobla...
Vincristine
Daunorubicin
Prednisone
Mitoxantrone
Cytosine Arabin...
Dexamethasone
Methotrexate (M...
Cytarabine
ASP
Mercaptopurine
Teniposide
Hydrocortisone
16 Years - PETHEMA Foundation View Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00720109 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Asparaginase
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Etoposide
Filgrastim
Hydrocortisone ...
Ifosfamide
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Methylprednisol...
Pegaspargase
Prednisone
Radiation Thera...
Vincristine Sul...
2 Years - 30 Years National Cancer Institute (NCI) View Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission NCT00268528 Childhood Acute...
Compliance Moni...
Laboratory Biom...
Mercaptopurine
Methotrexate
Questionnaire A...
Study of Socioe...
- 21 Years Children's Oncology Group View Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT01005758 Leukemia
cyclophosphamid...
cytarabine
dexamethasone
doxorubicin hyd...
etoposide phosp...
hydrocortisone ...
imatinib mesyla...
mercaptopurine
methotrexate
methylprednisol...
pegaspargase
prednisolone
prednisone
vincristine sul...
laboratory biom...
radiation thera...
18 Years - 50 Years National Cancer Institute (NCI) View Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) NCT00866307 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Prophylactic Cr...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia NCT00492856 Leukemia
mercaptopurine
methotrexate
tretinoin
18 Years - 120 Years SWOG Cancer Research Network View Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia NCT00003700 Leukemia
G-CSF
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
vincristine sul...
Allopurinol
15 Years - Alliance for Clinical Trials in Oncology View